Skip to main content
Equibles

ZJYL · Jin Medical International Ltd. · Metrics

Track ZJYL — free

Use ZJYL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ZJYL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.05 +0.03 (+1.48%) At close · Oct 23
Rebalance outlook locked
Market Cap
$143.35M
Shares
74.66M
Volume · Oct 23 4428 Avg daily vol (3M) 711.63K

ZJYL metrics

60 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.05
Market cap
$143.35M

Price action

20 metrics
Price change (1W)
-1.5%
Price change (30D)
+2.5%
Price change (3M)
-0.5%
Price change (6M)
-5.1%
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
107.2%
Annualized volatility (3M)
115.6%
Beta
0.7
RSI (14D)
48.1
Price vs SMA 50
-8.8%
Price vs SMA 200
—
Avg volume (3M)
711,629
Relative volume
0.0
Average dollar volume
$1.78M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
74.66M

Valuation

12 metrics
P / E (TTM)
122.3
Trailing earnings · reciprocal yield 0.8%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
7.3×
reciprocal yield 13.8%
P / book
4.7
reciprocal yield 21.2%
FCF yield
-4.9%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
0.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
30.6%
Operating margin
2.1%
Trailing 12 months
Net margin
5.9%
Gross profit (TTM)
$6.04M
Operating profit (TTM)
$417,941
Net income (TTM)
$1.17M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
-35.3%
Effective tax rate
7.8%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$3.79

Growth

11 metrics
Revenue growth YoY
-12.0%
Year over year
Net income growth YoY
-67.6%
Revenue (TTM)
$19.73M
Trailing 12 months
EPS growth YoY
-50.0%
Shares change YoY
+0.0%
Year over year · more shares
Revenue CAGR (3Y)
+2.5%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
-20.6%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
3.9%
Return on assets
2.1%
Debt / equity
—
Current ratio
2.0
EBITDA (TTM)
$657,350
Free cash flow (TTM)
−$6.96M
Quick ratio
1.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$9.08M
Total assets
$55.84M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$592,867
Capital expenditures (TTM)
$6.37M
R&D (TTM)
$1.78M
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
9.0%
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
4
13F filer change QoQ
+2
Institutional ownership
0.0%
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+356.5%
Holder tenure
2.6
Price vs estimated holder cost
-20.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.1%
Latest settlement · 1.5 days to cover
Days to cover
1.5d
Short-squeeze score
28 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1837821 CUSIP G5140V120 Visit website Investor relations